A multilocus genetic study evidences the association of autoimmune-related genes with Psoriatic Arthritis in Italian patients.


Journal

Immunobiology
ISSN: 1878-3279
Titre abrégé: Immunobiology
Pays: Netherlands
ID NLM: 8002742

Informations de publication

Date de publication:
07 2022
Historique:
received: 09 02 2022
revised: 28 04 2022
accepted: 21 05 2022
pubmed: 2 6 2022
medline: 3 8 2022
entrez: 1 6 2022
Statut: ppublish

Résumé

Psoriatic Arthritis (PsA) is an immune-mediated rheumatic disease caused by the interaction between environmental factors and genetic predisposition. Many of the risk loci associated with PsA susceptibility are shared with other autoimmune diseases, suggesting an involvement of the same pathways in these diseases. We investigated the association between nine selected polymorphisms and PsA susceptibility and their possible role in the modulation of the disease activity. We analysed 163 patients with PsA and 298 age and sex-matched healthy subjects. Our results showed the associations of five polymorphisms with the disease development: rs33980500 (TRAF3IP2), rs6920220 (TNFAIP3), rs27524 (ERAP1), rs7574865 (STAT4) and rs1800872 (IL10). Patients carrying the variant allele of TRAF3IP2 polymorphism had a higher number of tender/swollen joints and a higher Disease Activity Index for PsA score. The multilocus genetic risk profile showed a higher probability to develop the disease in subjects with at least four risk alleles.

Identifiants

pubmed: 35642993
pii: S0171-2985(22)00058-4
doi: 10.1016/j.imbio.2022.152232
pii:
doi:

Substances chimiques

IL10 protein, human 0
Minor Histocompatibility Antigens 0
STAT4 Transcription Factor 0
STAT4 protein, human 0
TRAF3IP2-AS1 antisense RNA, human 0
Interleukin-10 130068-27-8
RNA 63231-63-0
Aminopeptidases EC 3.4.11.-
ERAP1 protein, human EC 3.4.11.-
TNFAIP3 protein, human EC 3.4.19.12
Tumor Necrosis Factor alpha-Induced Protein 3 EC 3.4.19.12

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

152232

Informations de copyright

Copyright © 2022 Elsevier GmbH. All rights reserved.

Auteurs

Giada De Benedittis (G)

Department of Biomedicine and Prevention, Section of Genetics, University of Rome "Tor Vergata", 00133 Rome, Italy.

Andrea Latini (A)

Department of Biomedicine and Prevention, Section of Genetics, University of Rome "Tor Vergata", 00133 Rome, Italy.

Paola Conigliaro (P)

Rheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.

Paola Triggianese (P)

Rheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.

Alberto Bergamini (A)

Rheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.

Lucia Novelli (L)

UniCamillus-Saint Camillus International University of Health Sciences, 00131 Rome, Italy.

Cinzia Ciccacci (C)

UniCamillus-Saint Camillus International University of Health Sciences, 00131 Rome, Italy. Electronic address: cinzia.ciccacci@unicamillus.org.

Maria Sole Chimenti (MS)

Rheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.

Paola Borgiani (P)

Department of Biomedicine and Prevention, Section of Genetics, University of Rome "Tor Vergata", 00133 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH